Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015590 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01 | FLGT | BOLGER JOHN C | Dir | M - OptEx | $8.52 | +1,875 | 2,625 | +250% | +$16.0K |
| DM | 2022-03-03 | 2022-03-01 | FLGT | BOLGER JOHN C | Dir | S - Sale+OE | $61.36 | -1,875 | 2,000 | -48% | -$115.1K |
| DM | 2022-03-03 | 2022-03-01 | FLGT | BOLGER JOHN C | Dir | M - OptEx | $0.00 | -1,875 | 1,563 | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 625 | $3.93 | 2,625 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | M | A | 625 | $5.81 | 2,625 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-01 | S | D | 625 | $61.27 | 2,000 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-01 | S | D | 625 | $61.42 | 2,000 | D | — | — | (F1) The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 5 | Common | Common Stock | 2022-03-01 | S | D | 625 | $61.40 | 2,000 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-01 | M | A | 625 | $15.82 | 2,625 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | M | D | 625 | $0.00 | 2,813 | D | $15.82 · — to 2030-05-26 | 625 Common Stock | (F4) The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | M | D | 625 | $0.00 | 313 | D | $3.93 · — to 2028-05-18 | 625 Common Stock | (F2) The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | M | D | 625 | $0.00 | 1,563 | D | $5.81 · — to 2029-05-30 | 625 Common Stock | (F3) The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date. |